CymaBay Therapeutics
Gilead Sciences is committed to creating a healthier world for all people through innovation and the development of transformative therapies. With a focus on virology, oncology, and inflammation, Gilead invests in world-class science to combat some of the world's most devastating diseases. The company fosters an inclusive workplace with over 18,000 employees worldwide, dedicated to advancing scientific innovation, ensuring medicines reach those in need, and making a positive impact in communities. Gilead also emphasizes health equity, responsible corporate citizenship, and global health initiatives.
Industries
Nr. of Employees
medium (51-250)
CymaBay Therapeutics
Products
HIV and Viral Hepatitis Medications
A portfolio of medicines for HIV, hepatitis B and C, and emerging viruses.
Oncology Therapies
Innovative treatments for cancers, including cell therapy and targeted therapies.
Inflammation Treatments
Therapies aimed at inflammatory diseases with long-acting remissions or cures.
HIV and Viral Hepatitis Medications
A portfolio of medicines for HIV, hepatitis B and C, and emerging viruses.
Oncology Therapies
Innovative treatments for cancers, including cell therapy and targeted therapies.
Inflammation Treatments
Therapies aimed at inflammatory diseases with long-acting remissions or cures.
Services
Medical Information and Patient Safety
Providing medical information and reporting adverse events related to Gilead's medicines.
Medication Access and Distribution
Collaborating with communities worldwide to reduce barriers to care and expand access to medicines.
Corporate and Community Giving
Supporting patient advocates, healthcare professionals, and nonprofit organizations through the Gilead Foundation and corporate programs.
Research and Development
Investing in scientific research, clinical trials, and innovative therapies across therapeutic areas.
Medical Information and Patient Safety
Providing medical information and reporting adverse events related to Gilead's medicines.
Medication Access and Distribution
Collaborating with communities worldwide to reduce barriers to care and expand access to medicines.
Corporate and Community Giving
Supporting patient advocates, healthcare professionals, and nonprofit organizations through the Gilead Foundation and corporate programs.
Research and Development
Investing in scientific research, clinical trials, and innovative therapies across therapeutic areas.